GRACEcast

Blood-Based Mutation Testing: Circulating Tumor Cells and Tumor DNA


Listen Later

Dr. Ed Kim from the Levine Cancer Institute reviews the potential advantages and current limitations of blood-based testing for molecular markers using circulating tumor cells and circulating tumor DNA in identifying clinically important mutations.

...more
View all episodesView all episodes
Download on the App Store

GRACEcastBy Howard (Jack) West, MD